Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michèle Malassis-Séris"'
Autor:
Frédéric Rieux-Laucat, Frank Yates, Marie-Lise Gougeon, Chantal Lagresle-Peyrou, Brigitte Lemercier, Jean-Pierre de Villartay, Olivier Danos, Michèle Malassis-Séris, Allen Liu, Marina Cavazzana-Calvo, Alexandrine Garrigue, Estelle Morillon, Alain Fischer, Daniel Stockholm, Christophe Hue, Philippe Hajdari
Publikováno v:
Blood. 107:63-72
Severe combined immunodeficiency (SCID) caused by mutations in RAG1 or RAG2 genes is characterized by a complete block in T- and B-cell development. The only curative treatment is allogeneic hematopoietic stem cell transplantation, which gives a high
Autor:
Delphine Guy-Grand, Michèle Malassis-Séris, Philippe Henchoz, James P. DiSanto, Pierre Vassalli
Publikováno v:
European Journal of Immunology. 28:730-744
The small bowel mucosa contains within its villus epithelium a large number of intraepithelial lymphocytes (IEL) which upon activation are cytotoxic and release large quantities of IFN-gamma and TNF; these activities are increased by in vitro exposur
Publikováno v:
The Journal of Experimental Medicine
Mouse gut intraepithelial lymphocytes (IEL), whether thymodependent (CD4+ or CD8 alpha/beta +; TCR-alpha/beta +) or thymoindependent (CD8 alpha/alpha +; TCR-alpha/beta + or -gamma/delta +), all display cytotoxic activity in a "redirected lysis assay"
Autor:
Pierre Charneau, Julia Hauer, Julie Rivière, Marc Le Lorc'h, Jean-Pierre de Villartay, Pauline Soulas-Sprauel, Anne Galy, Michèle Malassis-Séris, Johanna Blondeau, Alexandrine Garrigue, Alain Fischer, Frederique Pâques, Nicole Brousse, Marina Cavazzana-Calvo, Serge Romana, Fatine Benjelloun, Daniel Stockholm, Annick Lim, Corinne Demerens-de Chappedelaine
Publikováno v:
Molecular Therapy
Molecular Therapy, Cell Press, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
Molecular Therapy, 2008, 16 (8), pp.1490-1499. ⟨10.1038/mt.2008.118⟩
Molecular Therapy, Nature Publishing Group, 2008, 16 (8), pp.1490-9. 〈10.1038/mt.2008.118〉
Molecular Therapy, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
Molecular Therapy, Nature Publishing Group, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
Molecular Therapy, Cell Press, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
Molecular Therapy, 2008, 16 (8), pp.1490-1499. ⟨10.1038/mt.2008.118⟩
Molecular Therapy, Nature Publishing Group, 2008, 16 (8), pp.1490-9. 〈10.1038/mt.2008.118〉
Molecular Therapy, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
Molecular Therapy, Nature Publishing Group, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
International audience; Patients with mutations in the Artemis gene display a complete absence of T- and B lymphocytes, together with increased cellular radiosensitivity; this leads to a radiosensitive severe combined immunodeficiency (RS-SCID). Allo
Autor:
Chantal Lagresle-Peyrou, Christophe Hue, Marina Cavazzana-Calvo, Alain Fischer, Allen Liu, Michèle Malassis-Séris, Christian A. J. Vosshenrich, James P. Di Santo
Publikováno v:
Blood
Blood, 2006, 108 (4), pp.1123-1128. ⟨10.1182/blood-2006-01-0061⟩
Blood, American Society of Hematology, 2006, 108 (4), pp.1123-1128. ⟨10.1182/blood-2006-01-0061⟩
Blood, 2006, 108 (4), pp.1123-1128. ⟨10.1182/blood-2006-01-0061⟩
Blood, American Society of Hematology, 2006, 108 (4), pp.1123-1128. ⟨10.1182/blood-2006-01-0061⟩
International audience; Severe combined immunodeficiency (SCID) is characterized by a complete block in T-lymphocyte differentiation. Most SCID also affects B-cell development or function, although a normal pool of pro-B cells is detectable. Treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7c0c1b7d2bcc0b3fe79f007566574b3
https://hal-pasteur.archives-ouvertes.fr/pasteur-03109725
https://hal-pasteur.archives-ouvertes.fr/pasteur-03109725